Angioimmunoblastic T-cell lymphoma (AITL)

Clinical trials for Angioimmunoblastic T-cell lymphoma (AITL) explained in plain language.

Never miss a new study

Get alerted when new Angioimmunoblastic T-cell lymphoma (AITL) trials appear

Sign up with your email to follow new studies for Angioimmunoblastic T-cell lymphoma (AITL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Completed 1

New drug combo shows promise for rare blood cancer in early trial

Disease control Completed

This study tests adding the drug romidepsin to standard chemotherapy (CHOEP) for young adults (ages 18-65) with a rare type of lymphoma called peripheral T-cell lymphoma. The goal is to see if this combination is safe and effective before patients undergo a stem cell transplant. …

Matched conditions: ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA (AITL)

Phase 1/2 • Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Disease control

Last updated Aug 21, 2026 00:00 UTC

Angioimmunoblastic T-cell lymphoma (AITL)

Get alerted when new Angioimmunoblastic T-cell lymphoma (AITL) trials appear

New drug combo shows promise for rare blood cancer in early trial